speb/financial-data huggingface dataset:
RARE cash_flow (quarterly, 2025-03-31) — Change In Receivables: 10000000.00
RARE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -56000000.00
RARE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 10000000.00
RARE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -46000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Common Stock: 94000.00
RARE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 144246000.00
RARE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 29000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 133286000.00
RARE balance_sheet (quarterly, 2025-03-31) — Current Assets: 699155000.00
RARE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 10487000.00
RARE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 10487000.00
RARE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 291668000.00
RARE balance_sheet (quarterly, 2025-03-31) — Current Provisions: 39721000.00
RARE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 9000000.00
RARE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 9000000.00
RARE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 96288650.00
RARE income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.57
RARE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -151000000.00
RARE income_statement (quarterly, 2025-03-31) — EBIT: -136000000.00
RARE income_statement (quarterly, 2025-03-31) — EBITDA: -127000000.00
RARE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1000000.00
RARE cash_flow (quarterly, 2025-03-31) — End Cash Position: 139000000.00
RARE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 157000.00
RARE balance_sheet (quarterly, 2025-03-31) — Finished Goods: 23118000.00
RARE balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -1258000.00
RARE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -182000000.00
RARE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -157000.00
RARE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -341000.00
RARE balance_sheet (quarterly, 2025-03-31) — Goodwill: 44406000.00
RARE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 220930000.00
RARE income_statement (quarterly, 2025-03-31) — Gross Profit: 110000000.00
RARE income_statement (quarterly, 2025-03-31) — Interest Expense: 14000000.00
RARE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 14000000.00
RARE income_statement (quarterly, 2025-03-31) — Interest Income: 7000000.00
RARE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 7000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Inventory: 46031000.00
RARE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 144246000.00
RARE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 120000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 68563000.00
RARE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 68563000.00
RARE balance_sheet (quarterly, 2025-03-31) — Liabilities Heldfor Sale Non Current: 794046000.00
RARE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 27786000.00
RARE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 27786000.00
RARE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 7000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Income: -151000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -151000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -151000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -151000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -151000000.00
RARE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -151000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -151000000.00
RARE cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -15000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Interest Income: -7000000.00
RARE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 137000000.00
RARE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -7000000.00
RARE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -1000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Net PPE: 260906000.00
RARE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -76684000.00
RARE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 30058000.00
RARE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 30058000.00
RARE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -127000000.00
RARE income_statement (quarterly, 2025-03-31) — Normalized Income: -151000000.00
RARE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -166000000.00
RARE income_statement (quarterly, 2025-03-31) — Operating Income: -143000000.00
RARE income_statement (quarterly, 2025-03-31) — Operating Revenue: 139000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 93903785.00
RARE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 59845000.00
RARE balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 60724000.00
RARE balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 7566000.00
RARE income_statement (quarterly, 2025-03-31) — Other Income Expense: 680000.00
RARE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 176524000.00
RARE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -6000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 62373000.00
RARE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 17123000.00
RARE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 837000.00
RARE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 367385000.00
RARE balance_sheet (quarterly, 2025-03-31) — Payables: 47450000.00
RARE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 180736000.00
RARE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
RARE income_statement (quarterly, 2025-03-31) — Pretax Income: -150000000.00
RARE cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 157000.00
RARE cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -15000000.00
RARE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
RARE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Receivables: 98839000.00
RARE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 29000000.00
RARE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 9000000.00
RARE income_statement (quarterly, 2025-03-31) — Research And Development: 166000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -4107924000.00
RARE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 137000000.00
RARE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 87000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Share Issued: 94066129.00
RARE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 40000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 144246000.00
RARE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -76684000.00
RARE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RARE income_statement (quarterly, 2025-03-31) — Tax Provision: 1000000.00
RARE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
RARE balance_sheet (quarterly, 2025-03-31) — Total Assets: 1311927000.00
RARE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 144246000.00
RARE balance_sheet (quarterly, 2025-03-31) — Total Debt: 38273000.00
RARE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 151246000.00
RARE income_statement (quarterly, 2025-03-31) — Total Expenses: 282000000.00
RARE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1160681000.00
RARE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 612772000.00
RARE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 869013000.00
RARE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -143000000.00
RARE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -157000.00
RARE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -157000.00
RARE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 162344.00
RARE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 7566000.00
RARE balance_sheet (quarterly, 2025-03-31) — Unrealized Gain Loss: 917000.00
RARE cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 157000.00
RARE balance_sheet (quarterly, 2025-03-31) — Work In Process: 22913000.00
RARE balance_sheet (quarterly, 2025-03-31) — Working Capital: 407487000.00
RARE income_statement (quarterly, 2025-06-30) — +Operating Expense: 251382000.00
RARE income_statement (quarterly, 2025-06-30) — +Total Revenue: 166496000.00
RARE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 34242000.00
RARE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 124464000.00
RARE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4374333000.00
RARE cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -780000.00
RARE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 51454000.00
RARE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 98460445.00
RARE income_statement (quarterly, 2025-06-30) — Basic EPS: -1.17
RARE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 139000000.00
RARE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2784000.00
RARE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 36297000.00
RARE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 96000.00
RARE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 166106000.00
RARE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 477385000.00
RARE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 83649000.00
RARE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 71065000.00
RARE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -108748000.00
RARE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -10136000.00
RARE cash_flow (quarterly, 2025-06-30) — Change In Inventory: 445000.00
RARE cash_flow (quarterly, 2025-06-30) — Change In Payable: -10136000.00
RARE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -10136000.00
RARE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -165000.00
RARE cash_flow (quarterly, 2025-06-30) — Change In Receivables: -12591000.00
RARE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -22447000.00
RARE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -12591000.00
RARE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 46123000.00
RARE balance_sheet (quarterly, 2025-06-30) — Common Stock: 96000.00
RARE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 151286000.00
RARE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 23002000.00
RARE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 132814000.00
RARE balance_sheet (quarterly, 2025-06-30) — Current Assets: 719788000.00
RARE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 11766000.00
RARE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 11766000.00
RARE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 293244000.00
RARE balance_sheet (quarterly, 2025-06-30) — Current Provisions: 47978000.00
RARE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 8609000.00
RARE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 8609000.00
RARE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 98460445.00
RARE income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.17
RARE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -114951000.00
RARE income_statement (quarterly, 2025-06-30) — EBIT: -99963000.00
RARE income_statement (quarterly, 2025-06-30) — EBITDA: -91354000.00
RARE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 3362000.00
RARE cash_flow (quarterly, 2025-06-30) — End Cash Position: 188644000.00
RARE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 83649000.00
RARE balance_sheet (quarterly, 2025-06-30) — Finished Goods: 26743000.00
RARE balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -843000.00
RARE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -111532000.00
RARE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -9000.00
RARE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -268000.00
RARE balance_sheet (quarterly, 2025-06-30) — Goodwill: 44406000.00
RARE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 219139000.00
RARE income_statement (quarterly, 2025-06-30) — Gross Profit: 143494000.00
RARE income_statement (quarterly, 2025-06-30) — Interest Expense: 14041000.00
RARE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 14041000.00
RARE income_statement (quarterly, 2025-06-30) — Interest Income: 5794000.00
RARE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 5794000.00
RARE balance_sheet (quarterly, 2025-06-30) — Inventory: 46498000.00
RARE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 151286000.00
RARE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 71065000.00
RARE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 51454000.00
RARE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 51454000.00
RARE balance_sheet (quarterly, 2025-06-30) — Liabilities Heldfor Sale Non Current: 782748000.00
RARE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 24531000.00
RARE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 24531000.00
RARE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 7000000.00
RARE income_statement (quarterly, 2025-06-30) — Net Income: -114951000.00
RARE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -114951000.00
RARE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -114951000.00
RARE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -114951000.00
RARE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -114951000.00
RARE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -115031000.00
RARE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -114951000.00
RARE cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: 0.00
RARE income_statement (quarterly, 2025-06-30) — Net Interest Income: -8247000.00
RARE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 73937000.00
RARE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -8247000.00
RARE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -88000.00
RARE balance_sheet (quarterly, 2025-06-30) — Net PPE: 255763000.00
RARE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2784000.00
RARE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -67853000.00
RARE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 30058000.00
RARE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 30058000.00
RARE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -91345000.00
RARE income_statement (quarterly, 2025-06-30) — Normalized Income: -114943890.00
RARE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -108748000.00
RARE income_statement (quarterly, 2025-06-30) — Operating Income: -107888000.00
RARE income_statement (quarterly, 2025-06-30) — Operating Revenue: 166496000.00
RARE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 96353634.00
RARE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 61241000.00
RARE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 66444000.00
RARE balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 7991000.00
RARE income_statement (quarterly, 2025-06-30) — Other Income Expense: 2131000.00
RARE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 174733000.00
RARE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -17545000.00
RARE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 60121000.00
RARE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 17398000.00
RARE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2140000.00
RARE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 311279000.00
RARE balance_sheet (quarterly, 2025-06-30) — Payables: 34242000.00
RARE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 167056000.00
RARE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
RARE income_statement (quarterly, 2025-06-30) — Pretax Income: -114004000.00
RARE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 3921000.00
RARE cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: 0.00
RARE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -15503000.00
RARE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2784000.00
RARE balance_sheet (quarterly, 2025-06-30) — Receivables: 124464000.00
RARE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 23002000.00
RARE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 8609000.00
RARE income_statement (quarterly, 2025-06-30) — Research And Development: 164736000.00
RARE balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 10200000.00
RARE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -4222875000.00
RARE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 89440000.00
RARE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 86646000.00
RARE balance_sheet (quarterly, 2025-06-30) — Share Issued: 96526668.00
RARE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 38446000.00
RARE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 151286000.00
RARE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -67853000.00
RARE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -1890.00
RARE income_statement (quarterly, 2025-06-30) — Tax Provision: 947000.00
RARE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
RARE balance_sheet (quarterly, 2025-06-30) — Total Assets: 1306265000.00
RARE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 151286000.00
RARE balance_sheet (quarterly, 2025-06-30) — Total Debt: 36297000.00
RARE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 158286000.00
RARE income_statement (quarterly, 2025-06-30) — Total Expenses: 274384000.00
RARE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1147979000.00
RARE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 586477000.00
RARE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 854735000.00
RARE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -107888000.00
RARE income_statement (quarterly, 2025-06-30) — Total Unusual Items: -9000.00
RARE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -9000.00
RARE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 173034.00
RARE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 7991000.00
RARE balance_sheet (quarterly, 2025-06-30) — Unrealized Gain Loss: 575000.00
RARE balance_sheet (quarterly, 2025-06-30) — Work In Process: 19755000.00
RARE balance_sheet (quarterly, 2025-06-30) — Working Capital: 426544000.00
RARE income_statement (quarterly, 2025-09-30) — +Operating Expense: 302832000.00
RARE income_statement (quarterly, 2025-09-30) — +Total Revenue: 159933000.00
RARE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 40573000.00
RARE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 112543000.00
RARE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4411531000.00
RARE cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -704000.00
RARE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 22067000.00
RARE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 99771297.00
RARE income_statement (quarterly, 2025-09-30) — Basic EPS: -1.81
RARE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 188644000.00
RARE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1278000.00
RARE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 33833000.00
RARE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 96000.00
RARE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 202510000.00
RARE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 425248000.00
RARE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2000.00
RARE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 117182000.00
RARE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -91423000.00
RARE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 45124000.00
RARE cash_flow (quarterly, 2025-09-30) — Change In Inventory: -5595000.00
RARE cash_flow (quarterly, 2025-09-30) — Change In Payable: 45124000.00
RARE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 45124000.00
RARE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 9905000.00
RARE cash_flow (quarterly, 2025-09-30) — Change In Receivables: 5425000.00
RARE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 54859000.00
RARE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 5425000.00
RARE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 25761000.00
RARE balance_sheet (quarterly, 2025-09-30) — Common Stock: 96000.00
RARE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9159000.00
RARE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
RARE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 27991000.00
RARE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 165249000.00
RARE balance_sheet (quarterly, 2025-09-30) — Current Assets: 643206000.00
RARE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 12142000.00
RARE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 12142000.00
RARE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 340022000.00
RARE balance_sheet (quarterly, 2025-09-30) — Current Provisions: 55277000.00
RARE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 8606000.00
RARE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 8606000.00
RARE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 99771297.00
RARE income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.81
RARE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -180413000.00
RARE income_statement (quarterly, 2025-09-30) — EBIT: -165392000.00
RARE income_statement (quarterly, 2025-09-30) — EBITDA: -156786000.00
RARE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 294000.00
RARE cash_flow (quarterly, 2025-09-30) — End Cash Position: 214699000.00
RARE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2000.00
RARE balance_sheet (quarterly, 2025-09-30) — Finished Goods: 23012000.00
RARE balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: 232000.00
RARE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -92701000.00
RARE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 678000.00
RARE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 820000.00
RARE balance_sheet (quarterly, 2025-09-30) — Goodwill: 44406000.00
RARE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 217349000.00
RARE income_statement (quarterly, 2025-09-30) — Gross Profit: 131942000.00
RARE income_statement (quarterly, 2025-09-30) — Interest Expense: 14148000.00
RARE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 14148000.00
RARE income_statement (quarterly, 2025-09-30) — Interest Income: 5863000.00
RARE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 5863000.00
RARE balance_sheet (quarterly, 2025-09-30) — Inventory: 52200000.00
RARE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9159000.00
RARE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 117182000.00
RARE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 22067000.00
RARE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 22067000.00
RARE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
RARE balance_sheet (quarterly, 2025-09-30) — Liabilities Heldfor Sale Non Current: 763735000.00
RARE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 21691000.00
RARE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 21691000.00
RARE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 7000000.00
RARE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
RARE income_statement (quarterly, 2025-09-30) — Net Income: -180413000.00
RARE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -180413000.00
RARE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -180413000.00
RARE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -180413000.00
RARE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -180413000.00
RARE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -180413000.00
RARE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -180413000.00
RARE cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: 0.00
RARE income_statement (quarterly, 2025-09-30) — Net Interest Income: -8285000.00
RARE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 118645000.00
RARE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -8285000.00
RARE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -185000.00
RARE balance_sheet (quarterly, 2025-09-30) — Net PPE: 249961000.00
RARE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1278000.00
RARE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -208190000.00
RARE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 30058000.00
RARE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 30058000.00
RARE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -157464000.00
RARE income_statement (quarterly, 2025-09-30) — Normalized Income: -180948620.00
RARE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -91423000.00
RARE income_statement (quarterly, 2025-09-30) — Operating Income: -170890000.00
RARE income_statement (quarterly, 2025-09-30) — Operating Revenue: 159933000.00
RARE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 96442027.00
RARE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 53215000.00
RARE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 66781000.00
RARE balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 7991000.00
RARE income_statement (quarterly, 2025-09-30) — Other Income Expense: -365000.00
RARE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 172943000.00
RARE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -11036000.00
RARE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 57862000.00
RARE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 18780000.00
RARE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1043000.00
RARE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 222738000.00
RARE balance_sheet (quarterly, 2025-09-30) — Payables: 40573000.00
RARE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 205822000.00
RARE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
RARE income_statement (quarterly, 2025-09-30) — Pretax Income: -179540000.00
RARE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 2000.00
RARE cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: 0.00
RARE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -16942000.00
RARE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1278000.00
RARE balance_sheet (quarterly, 2025-09-30) — Receivables: 112543000.00
RARE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 27991000.00
RARE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 8606000.00
RARE income_statement (quarterly, 2025-09-30) — Research And Development: 216212000.00
RARE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -4403288000.00
RARE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 135587000.00
RARE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 86620000.00
RARE balance_sheet (quarterly, 2025-09-30) — Share Issued: 96615061.00
RARE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 37265000.00
RARE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9159000.00
RARE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -208190000.00
RARE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 142380.00
RARE income_statement (quarterly, 2025-09-30) — Tax Provision: 873000.00
RARE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
RARE balance_sheet (quarterly, 2025-09-30) — Total Assets: 1190445000.00
RARE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 9159000.00
RARE balance_sheet (quarterly, 2025-09-30) — Total Debt: 33833000.00
RARE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 16159000.00
RARE income_statement (quarterly, 2025-09-30) — Total Expenses: 330823000.00
RARE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1174286000.00
RARE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 547239000.00
RARE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 834264000.00
RARE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -170890000.00
RARE income_statement (quarterly, 2025-09-30) — Total Unusual Items: 678000.00
RARE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 678000.00
RARE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 173034.00
RARE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 7991000.00
RARE balance_sheet (quarterly, 2025-09-30) — Unrealized Gain Loss: 588000.00
RARE balance_sheet (quarterly, 2025-09-30) — Work In Process: 29188000.00
RARE balance_sheet (quarterly, 2025-09-30) — Working Capital: 303184000.00
RARE income_statement (annual, 2025-12-31) — +Operating Expense: 1099000000.00
RARE income_statement (quarterly, 2025-12-31) — +Operating Expense: 291217000.00
RARE income_statement (annual, 2025-12-31) — +Total Revenue: 673000000.00
RARE income_statement (quarterly, 2025-12-31) — +Total Revenue: 207279000.00
RARE balance_sheet (annual, 2025-12-31) — Accounts Payable: 31000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 31000000.00
RARE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 158000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 158000000.00
RARE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -136000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -136000000.00
RARE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4451000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4451000000.00
RARE cash_flow (annual, 2025-12-31) — Amortization Of Securities: -4000000.00
RARE cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -516000.00
RARE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 57000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 57000000.00
RARE income_statement (annual, 2025-12-31) — Basic Average Shares: 98600000.00
RARE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 99900000.00
RARE income_statement (annual, 2025-12-31) — Basic EPS: -5.83
RARE income_statement (quarterly, 2025-12-31) — Basic EPS: -1.29
RARE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 184000000.00
RARE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 214699000.00
RARE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 182000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 182000000.00
RARE cash_flow (annual, 2025-12-31) — Capital Expenditure: -21000000.00
RARE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -938000.00
RARE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 36000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 36000000.00
RARE balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
RARE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
RARE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 421000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 421000000.00
RARE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 680000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 680000000.00
RARE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 478000000.00
RARE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 394192000.00
RARE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 236000000.00
RARE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -72247000.00
RARE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -466000000.00
RARE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -99829000.00
RARE cash_flow (annual, 2025-12-31) — Change In Account Payable: 24000000.00
RARE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 37012000.00
RARE cash_flow (annual, 2025-12-31) — Change In Inventory: -6000000.00
RARE cash_flow (quarterly, 2025-12-31) — Change In Inventory: 150000.00
RARE cash_flow (annual, 2025-12-31) — Change In Payable: 24000000.00
RARE cash_flow (quarterly, 2025-12-31) — Change In Payable: 37012000.00
RARE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 24000000.00
RARE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 37012000.00
RARE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -10000000.00
RARE cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -2740000.00
RARE cash_flow (annual, 2025-12-31) — Change In Receivables: -31000000.00
RARE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -33834000.00
RARE cash_flow (annual, 2025-12-31) — Change In Working Capital: -23000000.00
RARE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 588000.00
RARE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -31000000.00
RARE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -33834000.00
RARE cash_flow (annual, 2025-12-31) — Changes In Cash: 248000000.00
RARE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 222116000.00
RARE balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
RARE balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
RARE balance_sheet (annual, 2025-12-31) — Common Stock Equity: -80000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -80000000.00
RARE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 86000000.00
RARE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 6272000.00
RARE income_statement (annual, 2025-12-31) — Cost Of Revenue: 109000000.00
RARE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 29345000.00
RARE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 208000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 208000000.00
RARE balance_sheet (annual, 2025-12-31) — Current Assets: 951000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Current Assets: 951000000.00
RARE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 12000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 12000000.00
RARE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 12000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 12000000.00
RARE balance_sheet (annual, 2025-12-31) — Current Liabilities: 384000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 384000000.00
RARE balance_sheet (annual, 2025-12-31) — Current Provisions: 57000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 57000000.00
RARE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 35000000.00
RARE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 8785000.00
RARE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 35000000.00
RARE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 8785000.00
RARE income_statement (annual, 2025-12-31) — Diluted Average Shares: 98600000.00
RARE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 99900000.00
RARE income_statement (annual, 2025-12-31) — Diluted EPS: -5.83
RARE income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.29
RARE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -128556000.00
RARE income_statement (annual, 2025-12-31) — EBIT: -509000000.00
RARE income_statement (quarterly, 2025-12-31) — EBIT: -108217000.00
RARE income_statement (annual, 2025-12-31) — EBITDA: -474000000.00
RARE income_statement (quarterly, 2025-12-31) — EBITDA: -99432000.00
RARE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 4000000.00
RARE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -656000.00
RARE cash_flow (annual, 2025-12-31) — End Cash Position: 436000000.00
RARE cash_flow (quarterly, 2025-12-31) — End Cash Position: 436000000.00
RARE cash_flow (annual, 2025-12-31) — Financing Cash Flow: 478000000.00
RARE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 394192000.00
RARE balance_sheet (annual, 2025-12-31) — Finished Goods: 25000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 25000000.00
RARE cash_flow (annual, 2025-12-31) — Free Cash Flow: -487000000.00
RARE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -100767000.00
RARE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1000000.00
RARE balance_sheet (annual, 2025-12-31) — Goodwill: 44000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Goodwill: 44000000.00
RARE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 220000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 220000000.00
RARE balance_sheet (annual, 2025-12-31) — Gross PPE: 380000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 380000000.00
RARE income_statement (annual, 2025-12-31) — Gross Profit: 564000000.00
RARE income_statement (quarterly, 2025-12-31) — Gross Profit: 177934000.00
RARE income_statement (annual, 2025-12-31) — Interest Expense: 62000000.00
RARE income_statement (quarterly, 2025-12-31) — Interest Expense: 19469000.00
RARE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 62000000.00
RARE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 19469000.00
RARE income_statement (annual, 2025-12-31) — Interest Income: 25000000.00
RARE income_statement (quarterly, 2025-12-31) — Interest Income: 6512000.00
RARE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 25000000.00
RARE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 6512000.00
RARE balance_sheet (annual, 2025-12-31) — Inventory: 52000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Inventory: 52000000.00
RARE balance_sheet (annual, 2025-12-31) — Invested Capital: -80000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Invested Capital: -80000000.00
RARE cash_flow (annual, 2025-12-31) — Investing Cash Flow: 236000000.00
RARE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -72247000.00
RARE balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 57000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 57000000.00
RARE balance_sheet (annual, 2025-12-31) — Investments And Advances: 57000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 57000000.00
RARE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 86000000.00
RARE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 6272000.00
RARE balance_sheet (annual, 2025-12-31) — Land And Improvements: 17000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 17000000.00
RARE balance_sheet (annual, 2025-12-31) — Leases: 55000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Leases: 55000000.00
RARE balance_sheet (annual, 2025-12-31) — Liabilities Heldfor Sale Non Current: 1147000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Liabilities Heldfor Sale Non Current: 1147000000.00
RARE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 24000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 24000000.00
RARE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 24000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 24000000.00
RARE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 23000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 23000000.00
RARE balance_sheet (annual, 2025-12-31) — Minority Interest: 7000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Minority Interest: 7000000.00
RARE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 86000000.00
RARE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 6272000.00
RARE income_statement (annual, 2025-12-31) — Net Income: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Income: -128556000.00
RARE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -128556000.00
RARE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -128556000.00
RARE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -128556000.00
RARE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -128556000.00
RARE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -575000000.00
RARE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -128556000.00
RARE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -128556000.00
RARE cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -15000000.00
RARE cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
RARE income_statement (annual, 2025-12-31) — Net Interest Income: -37000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Interest Income: -12957000.00
RARE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 258000000.00
RARE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -71582000.00
RARE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -37000000.00
RARE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -12957000.00
RARE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 392000000.00
RARE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1000000.00
RARE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 273000.00
RARE balance_sheet (annual, 2025-12-31) — Net PPE: 244000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Net PPE: 244000000.00
RARE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -6000000.00
RARE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -938000.00
RARE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -300000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -300000000.00
RARE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 30000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 30000000.00
RARE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 30000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 30000000.00
RARE income_statement (annual, 2025-12-31) — Normalized EBITDA: -474000000.00
RARE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -99432000.00
RARE income_statement (annual, 2025-12-31) — Normalized Income: -575000000.00
RARE income_statement (quarterly, 2025-12-31) — Normalized Income: -128556000.00
RARE cash_flow (annual, 2025-12-31) — Operating Cash Flow: -466000000.00
RARE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -99829000.00
RARE income_statement (annual, 2025-12-31) — Operating Income: -535000000.00
RARE income_statement (quarterly, 2025-12-31) — Operating Income: -113283000.00
RARE income_statement (annual, 2025-12-31) — Operating Revenue: 673000000.00
RARE income_statement (quarterly, 2025-12-31) — Operating Revenue: 207279000.00
RARE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 96477569.00
RARE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 96477569.00
RARE balance_sheet (annual, 2025-12-31) — Other Current Assets: 61000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 61000000.00
RARE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 76000000.00
RARE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 76000000.00